Literature DB >> 1510511

A randomized study of the systemic effects of warm heart surgery.

G T Christakis1, J P Koch, K A Deemar, S E Fremes, L Sinclair, E Chen, T A Salerno, B S Goldman, S V Lichtenstein.   

Abstract

The technique of warm heart surgery is defined as continuous warm blood cardioplegia and normothermic cardiopulmonary bypass. Although the systemic effects of traditional myocardial protection are well known, the effects of warm heart surgery are not. In a prospective trial, 204 patients undergoing coronary artery bypass grafting were randomized to the warm heart surgery technique (normothermic group) or traditional intermittent cold blood cardioplegia and cardiopulmonary bypass (hypothermic group). The groups had similar heparin sodium requirement, activated clotting times, urine output, hematocrit, and blood product utilization. There were no differences in hemodynamics immediately after cardiopulmonary bypass. The normothermic patients had a higher incidence of spontaneous defibrillation at cross-clamp removal (84%) than the hypothermic patients (33%) (p less than 0.01). An increase in the flow rate of low K+ cardioplegia was necessary to eradicate electrical activity during aortic occlusion more often in the normothermic patients (20%) than in the hypothermic patients (3%) (p less than 0.01). When low K+ cardioplegia was ineffective, high K+ cardioplegia was necessary to eradicate electrical activity in 31% of the normothermic patients compared with 10% of the hypothermic patients (p less than 0.05). The total cardioplegia volume delivered to the normothermic group (4.7 +/- 1.9 L) was higher than that delivered to the hypothermic group (2.6 +/- 0.8 L) (p less than 0.01). Although urine output was similar in both groups, the serum K+ levels were higher in the normothermic group (5.7 +/- 0.8 mmol/L) than in the hypothermic group (5.3 +/- 0.8 mmol/L) (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510511     DOI: 10.1016/0003-4975(92)90434-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Valve replacement under retrograde warm-blood cardioplegia. Results in 287 patients.

Authors:  G A Tolis; N Sfyras; G Astras; G Georgiou
Journal:  Tex Heart Inst J       Date:  1998

2.  [Clinical advantages and myocardial protection of normothermal CPB--comparison with hypothermal CPB].

Authors:  Y Uno; S Horikoshi; H Emoto; H Miyamoto; H Suzuki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

3.  Warm blood cardioplegia.

Authors:  I Birdi; M B Izzat; A J Bryan; G D Angelini
Journal:  Br Heart J       Date:  1995-11

4.  Normothermic retrograde continuous cardioplegia for myocardial protection during cardiopulmonary bypass. A modified technique.

Authors:  M T Massie; J C Darrell; R F DiMarco; A G Marrangoni; L M Wei; S Miller; G F Woelfel; R V Pellegrini
Journal:  Tex Heart Inst J       Date:  1993

5.  Decreased incidence of low output syndrome with a switch from tepid to cold continuous minimally diluted blood cardioplegia in isolated coronary artery bypass grafting.

Authors:  Cristian Rosu; Maxime Laflamme; Clotilde Perrault-Hébert; Michel Carrier; Louis P Perrault
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-29

Review 6.  Limiting excessive postoperative blood transfusion after cardiac procedures. A review.

Authors:  V A Ferraris; S P Ferraris
Journal:  Tex Heart Inst J       Date:  1995

7.  Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.

Authors:  George D Bablekos; Antonis Analitis; Stylianos A Michaelides; Konstantinos A Charalabopoulos; Anastasia Tzonou
Journal:  Ann Transl Med       Date:  2016-06

8.  Intravascular leiomyoma with heart extension.

Authors:  Marcia Maria Morales; Alexandre Anacleto; João Carlos Leal; Sergio Carvalho; Jerônimo Del'Arco
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 9.  Interventions for protecting renal function in the perioperative period.

Authors:  Mathew Zacharias; Mohan Mugawar; G Peter Herbison; Robert J Walker; Karen Hovhannisyan; Pal Sivalingam; Niamh P Conlon
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.